23 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update.
61 Biggest Movers From Yesterday
Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
36 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
BIMI International Medical Inc. (NASDAQ: BIMI) rose 63.9% to $1.07 in pre-market trading as the company reported a narrower Q3 loss.
18 Stocks Moving in Thursday’s Pre-Market Session
Gainers
TSR, Inc. (NASDAQ: TSRI) rose 40.2% to $12.89 in pre-market trading after the company reported record revenue for its first quarter.
Eco Wave Power Reports Signing Of Memorandum Of Understanding With CIMC Offshore Engineering Institute Co. For Development, Commercialization Of Co.’s Technology In China, No Terms Disclosed
Eco Wave Power Global AB (publ) (Nasdaq: WAVE, Nasdaq First North: ECOWVE) ("Eco Wave Power") is pleased to announce the signing of a Memorandum of Understanding (MOU) with CIMC Offshore Engineering
Eco Wave Power Secures 1MW Installation, Grid Connection Permit (Small-Production Unit Registration Approval) For Its Planned Pilot Project In Portugal
In a significant regulatory milestone, Eco Wave Power Global AB (publ) (NASDAQ:WAVE, Nasdaq First North: ECOWVE)))) ("Eco Wave Power") is pleased to announce that its Portuguese subsidiary, EW
46 Biggest Movers From Yesterday
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday.
34 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday.
66 Biggest Movers From Yesterday
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
48 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.